Sunday, 28 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanomaУ вашего броузера проблема в совместимости с HTML5
Prof Antoni Ribas, (UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA) talks to ecancertv at AACR 2015 about the findings of a phase III trial, which showed pembrolizumab to be preferable to ipilimumab in advanced melanoma.
Опубликовано: 06-05-2015
Теги: Ipilimumab (Drug) Melanoma (Disease Or Medical Condition) Pembrolizumab Health (Industry)

Похожие видео
Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial24:18

Pembrolizumab shows promising activity against head and neck cancer

Pembrolizumab shows promising activity against head and neck cancer07:38

Pediatric Melanoma - The Pediatric/AYA Oncologist's Perspective

Pediatric Melanoma - The Pediatric/AYA Oncologist's Perspective16:54

ESMO Expert Video Report on Immunotherapy for Head and Neck Cancer

ESMO Expert Video Report on Immunotherapy for Head and Neck Cancer04:28

Мой аккаунт

Вход / Log In